Quark Biosciences, Inc.
- Home
- Companies
- Quark Biosciences, Inc.
- Products
- Quark - Model FusionQuest - 14 ...
Quark - Model FusionQuest -14 Druggable Fusion Genes Panel
14 druggable fusion genes, regardless of cancer origin, in one cost-effective panel.
Most popular related searches
Biomarker Content
12 Unknown Fusions
- ALK
- BRAF
- ESR1
- FGFR2
- FGFR3
- NTRK1
- NTRK2
- NTRK3
- PDGFRA
- PDGFRB
- RET
- ROS1
2 Mutations
- EGFRvIII
- MET
Druggable Fusion Detection
All possible gene rearragment detections in 14 fusion genes, all treatable with target therapy.
3x Cheaper, 4x Simpler, and 5x Faster
All the benefits of NextAmp™ with actionable results.
Ideal for Screening
Affordable solution providing an option for screening of driver fusion mutations.
Report in 2 Hours
Simultaneously detect 14 druggable genes with unknown fusion partners. The report is generated in 2 hours.
